Skip to main content

Advertisement

Log in

The loss of HBeAg without precore mutation results in lower HBV DNA levels and ALT levels in chronic hepatitis B virus infection

  • Original Article—Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

The aim of this study was to investigate the correlation between precore (PC)/basal core promoter (BCP) mutations and the viral loads or activity of hepatitis in patients with chronic hepatitis B virus (HBV) infection.

Methods

HBV genotypes, PC mutations, BCP mutations, HBV DNA levels, and serological markers of HBV were analyzed in all the patients with chronic HBV infection seen in Fujita Health University Hospital from June 2004 to November 2008 (n = 215).

Results

HBV genotype was C in 169 patients, B in 16, A in 3, F in 1, and unclassifiable in 5. Among the patients with genotype C, the prevalence of PC wild type was significantly lower in hepatitis B envelope antigen (HBeAg)(−) patients than in HBeAg(+) patients (9.5% versus 49.0%, P < 0.0001). Among HBeAg(−) patients, the patients with PC wild type had significantly lower serum viral loads and alanine aminotransferase (ALT) levels compared with those with PC mutant (P < 0.001). Among HBeAg(−) patients, the patients with genotype B had lower serum viral loads compared with those with genotype C (3.6 ± 0.9 versus 4.6 ± 1.6, P < 0.05), and the prevalence of BCP wild type was significantly higher in those with genotype B than in those with genotype C (58.3% versus 10.8%, P < 0.05).

Conclusions

Among HBeAg(−) patients with genotype C, the patients with PC wild type had significantly lower viral loads and ALT levels than those with PC mutant. This suggests that the patients with PC wild type may have better prognosis than those with PC mutant among HBeAg(−) patients with genotype C.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107.

    Article  PubMed  CAS  Google Scholar 

  2. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38:S158–68.

    Article  PubMed  Google Scholar 

  3. van Zonneveld M, Honkoop P, Hansen BE, Niesters HGM, Murad SD, de Man RA, et al. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B. Hepatology. 2004;39:804–10.

    Article  PubMed  CAS  Google Scholar 

  4. Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med. 2004;350:1118–29.

    Article  PubMed  CAS  Google Scholar 

  5. Lin CL, Liao LY, Liu CJ, Chen PJ, Lai MY, Kao JH, et al. Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B. J Gastroenterol. 2002;37:283–7.

    Article  PubMed  Google Scholar 

  6. Schiefke I, Klecker C, Maier M, Oesen U, Etzrodt G, Tannapfel A, et al. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a. Liver Int. 2004;24:98–104.

    Article  PubMed  CAS  Google Scholar 

  7. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. 1989;2:588–91.

    Article  PubMed  CAS  Google Scholar 

  8. Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol. 1994;68:8102–10.

    PubMed  CAS  Google Scholar 

  9. Takahashi K, Aoyama K, Ohno N, Iwata K, Akahane Y, Baba K, et al. The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection. J Gen Virol. 1995;76:3159–64.

    Article  PubMed  CAS  Google Scholar 

  10. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med. 1991;324:1705–9.

    PubMed  CAS  Google Scholar 

  11. Aritomi T, Yatsuhashi H, Fujino T, Yamasaki K, Inoue O, Koga M, et al. Association of mutations in the core promoter and precore region of hepatitis virus with fulminant and severe acute hepatitis in Japan. J Gastroenterol Hepatol. 1998;13:1125–32.

    Article  PubMed  CAS  Google Scholar 

  12. Chen CH, Lee CM, Lu SN, Changchien CS, Eng HL, Huang CM, et al. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan. J Clin Microbiol. 2005;43:6000–6.

    Article  PubMed  CAS  Google Scholar 

  13. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol. 1988;69:2575–83.

    Article  PubMed  CAS  Google Scholar 

  14. Stuyver LS, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, et al. A new genotype of hepatitis B virus: complete genome a phylogenetic relatedness. J Gen Virol. 2000;81:67–74.

    PubMed  CAS  Google Scholar 

  15. Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology. 2001;34:590–4.

    Article  PubMed  CAS  Google Scholar 

  16. Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, et al. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology. 2003;125:444–51.

    Article  PubMed  Google Scholar 

  17. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology. 2000;118:554–9.

    Article  PubMed  CAS  Google Scholar 

  18. Lindh M, Hannoun C, Dhillon AP, Norkrans G, Horal P. Core promotor mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis. 1999;179:775–82.

    Article  PubMed  CAS  Google Scholar 

  19. Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, Ichida T, et al. A case–control study for clinical and molecular biological differences between hepatitis B viruses of genotype B and C. Hepatology. 2001;33:218–23.

    Article  PubMed  CAS  Google Scholar 

  20. Ding X, Mizokami K, Yao G, Xu B, Orito E, Ueda R, et al. Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China. Intervirology. 2001;44:43–7.

    Article  PubMed  CAS  Google Scholar 

  21. Lindh M, Andersson A. Gusdal. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus—large-scale analysis using a new genotyping method. J Infect Dis. 1997;175:1285–93.

    Article  PubMed  CAS  Google Scholar 

  22. Lindh M, Gustavson K, Mardberg G, Norkrans AP, Dhillon PH. Mutation of nucleotide 1762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriers. J Med Virol. 1998;55:185–90.

    Article  PubMed  CAS  Google Scholar 

  23. Kessler HH, Pierer K, Dragon E, Lackner H, Santner B, Stünzner D, et al. Evaluation of a new assay for HBV DNA quantitation in patients with chronic hepatitis B. Clin Diagn Virol. 1998;9:37–43.

    Article  PubMed  CAS  Google Scholar 

  24. Misawa N, Matsumoto A, Tanaka E, Rokuhara A, Yoshizawa K, Umemura T, et al. Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics. J Med Virol. 2006;78:68–73.

    Article  PubMed  CAS  Google Scholar 

  25. Yoo BC, Park JW, Kim HJ, Lee DH, Cha YJ, Park SM. Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea. J Hepatol. 2003;38:98–103.

    Article  PubMed  CAS  Google Scholar 

  26. Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, et al. U.S. HBV Epidemiology Study Group. Prevalence of HBV precore/core promoter variants in the United States. Hepatology. 2003;38:619–28.

    Article  PubMed  CAS  Google Scholar 

  27. Lindh M, Horal P, Dhillon AP, Norkrans G. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat. 2000;7:258–67.

    Article  PubMed  CAS  Google Scholar 

  28. Sugauchi F, Kumada H, Sakugawa H, Komatsu M, Niitsuma H, Watanabe H, et al. Two subtypes of genotype B (Ba and Bj) of hepatitis B virus in Japan. Clin Infect Dis. 2004;38:1222–8.

    Article  PubMed  CAS  Google Scholar 

  29. Sugauchi F, Orito E, Ichida T, Kato H, Sakugawa H, Kakumu S, et al. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology. 2003;124:925–32.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kentaro Yoshioka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kawabe, N., Hashimoto, S., Harata, M. et al. The loss of HBeAg without precore mutation results in lower HBV DNA levels and ALT levels in chronic hepatitis B virus infection. J Gastroenterol 44, 751–756 (2009). https://doi.org/10.1007/s00535-009-0061-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-009-0061-7

Keywords

Navigation